lants typically respond to environmental stress such as insect herbivory, mechanical damage, and ultraviolet (UV) irradiation by inducing defense-related proteins (1, 2). Among these proteins, proteinase inhibitors I (Inh I) and II (Inh II) isolated from potato leaves are two well-characterized chymotrypsin inhibitors. Both proteins accumulate in potato and tomato leaves and are involved in signal transduction pathways in the plant's protective response against environmental herbivores and pathogens (3-5). In addition, these inhibitors have also been reported to have an inhibitory effect on irradiation-induced cell transformation in mammalian cells (6). We reported previously that both Inh I and Inh II block UVB-or UVC-induced transcription activator protein 1 (AP-1) activity in mouse JB6 cells (7). Considering the critical role that AP-1 activation plays in malignant cellular transformation and tumorigenesis (8-15), the inhibitory effects of these compounds on AP-1 activation may explain their reported antitumor effects. The precise mechanism explaining the inhibition is, however, unclear.
P
lants typically respond to environmental stress such as insect herbivory, mechanical damage, and ultraviolet (UV) irradiation by inducing defense-related proteins (1, 2) . Among these proteins, proteinase inhibitors I (Inh I) and II (Inh II) isolated from potato leaves are two well-characterized chymotrypsin inhibitors. Both proteins accumulate in potato and tomato leaves and are involved in signal transduction pathways in the plant's protective response against environmental herbivores and pathogens (3) (4) (5) . In addition, these inhibitors have also been reported to have an inhibitory effect on irradiation-induced cell transformation in mammalian cells (6) . We reported previously that both Inh I and Inh II block UVB-or UVC-induced transcription activator protein 1 (AP-1) activity in mouse JB6 cells (7) . Considering the critical role that AP-1 activation plays in malignant cellular transformation and tumorigenesis (8) (9) (10) (11) (12) (13) (14) (15) , the inhibitory effects of these compounds on AP-1 activation may explain their reported antitumor effects. The precise mechanism explaining the inhibition is, however, unclear.
AP-1 is an inducible eukaryotic transcription factor composed of products of the jun and fos oncogene families that form Jun-Jun or Jun-Fos dimers (16, 17) . When stimulated, AP-1 binds to specific transactivation promoter regions or TREs (12-O-tetradecanoylphorbol 13-acetate response elements) on DNA to induce transcription of genes involved in cell proliferation, metastasis, and metabolism (18) . Many positive and negative components are involved in the regulation of AP-1 activity. Among these regulators, mitogen-activated protein kinase (MAP kinase) signaling pathways are common mediators of AP-1 function (19) . However, we have previously observed that both Inh I and Inh II fail to block extracellular signalregulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), or p38 kinase, three members of the MAP kinase family (7) . This observation suggested that inhibition of AP-1 activity by Inh I and Inh II is mediated by a mechanism independent of the MAP kinase pathways.
Nuclear factor B (NFB) is another eukaryotic transcriptional factor that appears to be critically involved in regulating the expression of a variety of genes that participate in the inflammatory response and suppression of apoptosis, as well as cell proliferation (20, 21) . Furthermore, subunits of AP-1 and NFB are able to ''cross-talk,'' and thus both transcription factors may play a role in cellular transformation (22, 23) . Recent reports have indicated that both AP-1 and NFB are involved in tumor promoter-induced progression in the human keratinocyte transformation model (24, 25) .
To elucidate how the proteinase inhibitors suppress AP-1 activity and whether NFB is involved in this mechanism, we investigated changes in both AP-1 and NFB activities and DNA-binding capacities in response to cellular treatment with Inh I and Inh II and exposure to UVB, respectively. We also determined changes in the AP-1 protein composition after treatment with the Inh I and Inh II and subsequent exposure to UVB in JB6 cells. In this paper, we report that both Inh I and Inh II block UVB-induced activities of AP-1, but not NFB. Additionally, the regulation of the AP-1 protein compositional pattern by Inh I and Inh II appears to be involved in the inhibition of AP-1 activity.
Materials and Methods
Cell Culture and Reagents. AP-1 or NFB luciferase reporter plasmid stably transfected mouse epidermal JB6 P ϩ 1-1 and the JB6 mouse epidermal cell line Cl 41 were constructed as previously reported (7, 26) . The cells were cultured in monolayers at 37°C under a 5% CO 2 ͞95% air atmosphere in Eagle's minimal essential medium (MEM) containing 5% fetal bovine serum (FBS), 2 mM L-glutamine, and 25 g͞ml gentamicin. FBS and MEM were from BioWhittaker (Walkersville, MD); aprotinin and leupeptin were from Sigma; rabbit polyclonal IgG against c-Jun, JunB, JunD or c-Fos, FosB, Fra-1, and Fra-2 (TransCruz Gel Supershift reagent, 200 g͞0.1 ml) were from Santa Cruz Biotechnology; and Inh I and Inh II were isolated from potato tubers and characterized as described previously (3, 4) . , suspended in 100 l of 5% FBS in MEM, were added to each well of a 96-well plate. Plates were incubated for 24 h at 37°C in a humidified atmosphere of 5% CO 2 ͞95% air. The cells were then starved by culturing them in 0.1% FBS in MEM for 24 h before Abbreviations: Inh I, proteinase inhibitor I; Inh II, proteinase inhibitor II; AP-1, transcription activator protein 1; MAP kinase, mitogen-activated protein kinase; NFB, nuclear factor B; UVB, ultraviolet B. ‡ To whom reprint requests should be addressed. E-mail: zgdong@smig.net.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. treatment for 30 min with or without Inh I and Inh II at the concentrations indicated. The cells were then exposed to UVB (4 kJ͞m 2 ), cultured for an additional 12 h and extracted with lysis buffer (0.1 M potassium phosphate buffer, pH 7.8͞1% Triton X-100͞1 mM DTT͞2 mM EDTA), and the luciferase activity was measured with a luminometer (Monolight 2010). Results are expressed as relative AP-1 activity Ϯ standard deviation.
Isolation of Nuclear Proteins and Gel-Shift and Gel-Supershift Assays.
Nuclear protein extracts were prepared from JB6 Cl 41 cells, and electrophoretic mobility-shift and supershift assays were performed essentially as reported previously (27) (28) (29) . Briefly, Cl 41 cells were cultured in 10-cm dishes and starved in 0.1% FBS in MEM at 37°C in a 5% CO 2 incubator as described previously. After a 24-h starvation, the cells were treated for 30 min with various concentrations of Inh I or Inh II as indicated and then exposed to UVB (4 kJ͞m 2 ) and incubated another 12 h. The cells were then harvested and disrupted in 500 l of lysis buffer A (25 mM Hepes, pH 7.8͞50 mM KCl͞0.5% Nonidet P-40͞100 M DTT containing 10 g͞ml leupeptin, 25 g͞ml aprotinin, and 1 mM PMSF). After a 1-min centrifugation (16,000 ϫ g, 4°C), the nuclei-containing pellet was washed once with 500 l of buffer B (buffer A without Nonidet P-40), resuspended in 150 l of extraction buffer [buffer B but with 500 mM KCl and 10% (vol͞vol) glycerol], and shaken for 30 min at 4°C. The resulting nuclear extracts were stored at Ϫ70°C until analysis. The DNAbinding reaction (for electrophoretic mobility-shift assay) was carried out at room temperature for 30 min in a mixture containing 4 g of nuclear proteins, 1 g of poly(deoxyinosinic acid⅐deoxycytidylic acid) [poly(dI⅐dC)], and 15,000 cpm of a 32 P-labeled double-stranded A P-1 oligonucleotide (5Ј-CGCTTGATGAGTCAGCCGGAA-3Ј) or NFB oligonucleotide (5Ј-TAGTTGAGGGGACTTTCCCAGGCA-3Ј). The samples were then fractionated through a 5% polyacrylamide gel in 0.5ϫ TBE (1ϫ TBE is 90 mM Tris͞64.6 mM boric acid͞2.0 mM EDTA, pH 8.0). Electrophoretic mobility-supershift assays of AP-1 were performed by preincubating 4 g of nuclear protein with 4 g of the specific antibody against c-Jun, JunB, JunD, c-Fos, FosB, Fra-1, or Fra-2 at 4°C for 2 h and then processing as described above. Completed gels were then dried and analyzed by using the Storm 840 Phospho-Image System (Molecular Dynamics).
Western Immunoblotting. Cl 41 cells were starved and treated as described for electrophoretic mobility-shift assay. The cells were lysed with 1ϫ SDS sample buffer, heated at 95°C for 5 min, and fractionated by 8% polyacrylamide͞SDS gel electrophoresis. Proteins were then transferred to Immobilon membranes (Mil- Antibody-bound proteins were detected by chemiluminescence (ECL, Amersham Pharmacia Biotech) and analyzed by using the Storm 840 Phospho-Image System (Molecular Dynamics).
Statistical Analysis. Significant differences in AP-1 activity were determined by using Student's t test. The results are expressed as means Ϯ standard deviation (SD).
Results and Discussion
Inh I and Inh II Block UVB-Induced AP-1 Activity but Increase UVBInduced NFB Activity. Inh I and Inh II are effective proteinase inhibitors of chymotrypsin and trypsin (3, 4) and have been reported to display anticarcinogenic properties by suppressing irradiation-induced transformation of mouse embryo fibroblasts (6) . Although the mechanisms underlying these effects are poorly understood, the inhibition of chymotrypsin-like enzymes is believed to play an important role in the reported anticarcinogenic effect (30) . We have previously demonstrated that blocking AP-1 activity inhibits tumor transformation, suggesting that AP-1 activity is necessary for tumor promoter-induced transformation (10) . To investigate whether Inh I or Inh II suppresses UVB-induced AP-1 activity, we used the mouse epidermal JB6 cell model, which is a well-established cell line used extensively to study tumor promotion (31) (32) (33) (34) , and a stable transfectant with the AP-1 luciferase reporter (33, 34) . Our data showed that Inh I or Inh II had no significant effect on AP-1 activity in JB6 cells (Fig. 1A) . However, both Inh I and Inh II markedly blocked UVB-induced AP-1 activity (P Ͻ 0.05; Fig.  1B) . Neither of the inhibitors, at the tested concentrations, was toxic to the cells as indicated by the incorporation of [ 3 H]thymidine (data not shown). These findings are also consistent with our previous work (7) . The data indicated that the compounds suppressed AP-1 activity effectively with little effect on cellular metabolism.
NFB is a dimer composed of two DNA-binding subunits, NFB p50 and p65, which belong to the c-rel protooncogene family (20) . Communication or cross-talk between AP-1 and NFB has been reported before (23) . In that report, the bZIP regions of c-Fos and c-Jun interacted with NFB p65 through the Rel homology domain. The complex of NFB p65 and Jun or Fos increased DNA-binding activity and biological function by both the NFB and AP-1 response elements. In yet another study, the activation of NFB and AP-1 was shown to be crucially involved in UV-induced expression of FasL, an apoptosis-related ligand. However, in the current experiments, both Inh I and Inh II significantly enhanced NFB activity induced by UVB (P Ͻ 0.05; Fig. 2B ). The enhancement of Inh I and Inh II on UVB-induced NFB activity did not appear to be dose-dependent (Fig. 2B) . Neither Inh I nor Inh II, at the concentrations indicated, induced a significant effect on NFB activity in JB6 cells (Fig. 2 A) . The markedly different effects of Inh I and Inh II on UVB-induced AP-1 and NFB activation suggest that UVB-activated AP-1 and NFB transactivation occur by different mechanisms. Neither Inh I nor Inh II Had an Effect on UVB-Induced AP-1 or NFB DNA Binding. To determine whether Inh I or Inh II has an effect on UVB-induced AP-1 or NFB binding activity, electrophoretic mobility gel-shift assays were performed. UVB (4 kJ͞m 2 ) induced a significant increase in both AP-1 and NFB DNAbinding activities (lane 3, Figs. 3 and 4) . In both cases, the binding of the probe was effectively eliminated by adding a 10-fold excess of unlabeled AP-1 or NFB oligonucleotide (lane 1, Figs. 3 and  4) , confirming that the band was only either AP-1 or NFB. The results also showed that Inh I and Inh II had no effect on the UVB-induced increase in AP-1 or NFB DNA binding (Figs. 3  and 4, lanes 3, 4, and 5) . These results indicate that the observed effects of Inh I and Inh II on UVB-induced AP-1 or NFB transactivation did not occur through changes in DNA binding by AP-1 or NFB.
The DNA transactivation potential of AP-1 and NFB depends not only on the quantities of particular proteins present but also on their distribution patterns (22, 35, 36) . Any change in the level of expression of these components leads to changes in their transactivational activity. Results of the present study suggested that Inh I and Inh II differentially affected the response of UVB-induced AP-1 transactivation by regulating the dimeric composition of AP-1 rather than the DNA-binding activity.
The Composition of UVB-Induced AP-1 Was Changed by Inh I and Inh
II. Because Inh I and Inh II inhibited UVB-induced AP-1 activity, but did not affect UVB-induced AP-1 binding to its DNA recognition site, we propose that the inhibitory effect of Inh I and Inh II on UVB-induced AP-1 transcriptional activity happens as a result of alterations in the composition of the AP-1 complex proteins. To test this hypothesis, we used electrophoretic mobility-supershift assays to identify AP-1-associated proteins that were induced by Inh I and Inh II. In this assay, the respective antibody (c-Jun, JunB, JunD, c-Fos, FosB, Fra-1, or Fra-1) deactivates its target protein, thereby preventing that protein from interacting with the AP-1 DNA-binding site. This interaction would result in a decreased signal or an extra shifted band (i.e., ''supershift''), suggesting that the specific protein is an important component of AP-1. Results indicated that, in unstimulated JB6 cells, the AP-1 is composed mainly of JunD and Fra-2 proteins (Fig. 5A, lanes 5 and 9) . UVB stimulation induced a significant increase in c-Jun, c-Fos (Fig. 5B, lanes 4 and 7 and  Fig. 7 , which is published as supplemental data on the PNAS web site, www.pnas.org), and a mild increase in JunB (Fig. 5B , lane 5) in the composition of AP-1 but a decrease in JunD and Fra-2 ( Fig. 5B, lanes 6 and 10) compared with the unstimulated AP-1 composition (Fig. 5A, lanes 5 and 9) . When the cells were treated for 30 min with Inh I or Inh II before UVB irradiation, the AP-1 composition pattern changed and JunD (Fig. 8 , which is published as supplemental data) and Fra-2 components again were increased ( Fig. 5 C and D, lanes 5 and 9) and c-Jun or c-Fos were markedly decreased (Fig. 5 C and D, lanes 3 and 6) .
Western blot analysis showed that UVB stimulation resulted in decreased expression of JunD and Fra-2 proteins compared with unstimulated control and increased expression of c-Jun, JunB, c-Fos, FosB, and Fra-1 proteins (Fig. 6) . Pretreatment of cells for 30 min with Inh I or Inh II reversed the UVB-induced decrease of JunD and Fra-2. Inh I and Inh II also inhibited UVB-induced expression of c-Jun and c-Fos proteins (Fig. 6) . The results indicated that the inhibitory effect of Inh I and Inh II on AP-1 transcriptional activity appears to be mediated through an alteration in the protein composition of the AP-1 complex.
Inh I and Inh II have been shown to prevent x-ray irradiationinduced mammalian cell transformation (6) . Our previous work suggested that the compounds suppressed tumor promoter UV-induced AP-1 activity (7). However, the mechanism explaining the inhibition of Inh I and II on AP-1 activity is poorly understood, probably because AP-1 DNA-binding affinity and transactivation potential are affected by many complicated factors.
AP-1 can be modified at the transcriptional, posttranscriptional, and posttranslational levels. These modifications alter the DNA-binding affinity and transactivation potential of AP-1 (19) .
Evidence showed that the MAP kinase superfamily, including ERK1͞2, JNKs, and p38 kinase, mediates the expression of ''immediate-early'' genes, c-jun and c-fos, and the phosphorylation of the gene products, c-Jun and c-Fos, thus influencing transcriptional and posttranslational regulation of AP-1 activity, respectively (19) . Our previous observation, however, did not demonstrate that Inh I and Inh II suppressed UVB-induced phosphorylation or activity of MAP kinases, including ERKs, p38 kinase, or JNKs (7), thus indicating that the inhibition of UV-induced AP-1 activity by Inh I and II might be through MAP kinase-independent pathways. Our present data show that UVB induced increases in c-Jun and c-Fos expression, but decreased JunD and Fra-2 expression. Inh I or Inh II reversed these changes in AP-1 composition. Thus, the inhibition of AP-1 activity and cell transformation by Inh I and II is probably not connected to MAP kinases or kinases upstream (e.g., protein kinase C, Ras͞Raf, or MAP kinase kinases). The results suggested that the inhibition of cell transformation by the compounds might be targeted directly at the transcriptional factor AP-1, but not the MAP kinase cascades.
Several proteins can form complexes that bind to AP-1 sites. These proteins differ considerably in their ability to activate transcription of target genes. For instance, both c-Fos and Fra-1 form stable heterodimers with any of the Jun proteins, with similar DNA-binding activities and specificities, yet c-Fos has a much stronger transactivational activity (37) . It was reported that elevated expression of JunD decreased cell transformation and AP-1 activity (38) . In our study, AP-1 activity induced by UVB stimulation plus Inh I or Inh II had a different pattern of protein composition mainly because of the expression of JunD and Fra-2, which may be responsible for the changes observed in the AP-1 transactivation capacity.
The three Jun proteins are closely related in amino acid sequence, particularly in the region (HR-2) containing the DNA-binding domain (38) . This may explain why in our experiment, when inhibited by Inh I or Inh II, the UVB-induced AP-1 complex had a high proportion of JunD or Fra-2 proteins and did not show a decrease in its DNA-binding ability. These results are in consensus with a significant report in which JunD partially suppressed cell transformation by an activated ras gene, whereas c-Jun cooperated with ras to transform cells (35) . Others have reported that the inhibition of proliferation by vitamin D is accompanied by an increase of JunD in the AP-1 complex (36). Sonoda et al. (39) showed that reversion of the malignant tumor phenotype to the normal one by oxamflatin is by means of induction of JunD. These data indicated that two closely related transcription factor proteins could function in an opposing manner. Although the Jun family members can bind to the same DNA sequences, they have been shown to do so with different affinities and thus may elicit different responses with regard to expression of target genes (40) (41) (42) .
Taken together, the results presented in this study demonstrate that Inh I and Inh II specifically inhibit UVB-induced AP-1 activity by regulating its protein compositional pattern. The up-regulation of JunD and Fra-2 by these compounds was critical for the down-regulation of UVB-induced AP-1 activity to occur. 
